| Bristol Myers Squibb (BMY) |
United States |
$144.867B |
10.04 |
| Amgen (AMGN) |
United States |
$144.431B |
15.59 |
| CSL (CSLLY) |
Australia |
$98.706B |
0.00 |
| Gilead Sciences (GILD) |
United States |
$85.949B |
9.15 |
| Moderna (MRNA) |
United States |
$64.799B |
129.10 |
| Vertex Pharmaceuticals (VRTX) |
United States |
$56.197B |
23.14 |
| Illumina (ILMN) |
United States |
$55.630B |
80.22 |
| Regeneron Pharmaceuticals (REGN) |
United States |
$55.043B |
15.76 |
| BioNTech SE (BNTX) |
Germany |
$46.558B |
33.76 |
| Biogen (BIIB) |
United States |
$42.187B |
9.66 |
| Alexion Pharmaceuticals (ALXN) |
United States |
$38.345B |
14.57 |
| BeiGene (BGNE) |
Cayman Islands |
$29.309B |
0.00 |
| Seagen (SGEN) |
United States |
$26.768B |
46.24 |
| Genmab (GMAB) |
Denmark |
$24.320B |
28.52 |
| Genmab (GNMSF) |
Denmark |
$23.086B |
5.31 |
| Horizon Therapeutics Public (HZNP) |
Ireland |
$20.710B |
26.48 |
| SINO PHARMACEUT (SBMFF) |
Hong Kong, SAR China |
$20.582B |
0.00 |
| CureVac (CVAC) |
Germany |
$20.559B |
0.00 |
| Incyte (INCY) |
United States |
$18.170B |
35.92 |
| Exact Sciences (EXAS) |
United States |
$16.596B |
0.00 |
| Alnylam Pharmaceuticals (ALNY) |
United States |
$15.951B |
0.00 |
| Bio-Techne Corp (TECH) |
United States |
$15.610B |
82.08 |
| Zai Lab (ZLAB) |
China |
$14.480B |
0.00 |
| BioMarin Pharmaceutical (BMRN) |
United States |
$14.058B |
128.22 |
| ARGENX SE-ADR (ARGX) |
Netherlands |
$13.971B |
0.00 |
| Guardant Health (GH) |
United States |
$11.411B |
0.00 |
| QIAGEN (QGEN) |
Netherlands |
$10.665B |
18.94 |
| Novavax (NVAX) |
United States |
$9.758B |
0.00 |
| Repligen (RGEN) |
United States |
$9.441B |
85.13 |
| AbCellera Biologics (ABCL) |
|
$8.602B |
0.00 |
| CRISPR Therapeutics AG (CRSP) |
Switzerland |
$8.080B |
0.00 |
| Mirati Therapeutics (MRTX) |
United States |
$8.057B |
0.00 |
| Exelixis (EXEL) |
United States |
$8.010B |
127.80 |
| Acceleron Pharma (XLRN) |
United States |
$7.654B |
0.00 |
| Ultragenyx Pharmaceutical (RARE) |
United States |
$7.482B |
0.00 |
| Fate Therapeutics (FATE) |
United States |
$7.213B |
0.00 |
| Ascendis Pharma (ASND) |
Denmark |
$7.105B |
0.00 |
| Denali Therapeutics (DNLI) |
United States |
$6.532B |
234.35 |
| Halozyme Therapeutics (HALO) |
United States |
$6.127B |
33.62 |
| Sarepta Therapeutics (SRPT) |
United States |
$6.067B |
0.00 |
| Blueprint Medicines (BPMC) |
United States |
$5.627B |
17.13 |
| Vir Biotechnology (VIR) |
United States |
$5.489B |
0.00 |
| Galapagos (GLPG) |
Belgium |
$4.991B |
0.00 |
| SWEDISH ORP BIO (BIOVF) |
Sweden |
$4.950B |
17.93 |
| Adaptive Biotechnologies (ADPT) |
United States |
$4.846B |
0.00 |
| I-Mab (IMAB) |
China |
$4.698B |
0.00 |
| Intellia Therapeutics (NTLA) |
United States |
$4.569B |
0.00 |
| Biohaven Pharmaceutical Holding (BHVN) |
United States |
$4.545B |
0.00 |
| Twist Bioscience (TWST) |
United States |
$4.532B |
0.00 |
| Beam Therapeutics (BEAM) |
United States |
$4.501B |
0.00 |
| NeoGenomics (NEO) |
United States |
$4.494B |
762.20 |
| Certara (CERT) |
United States |
$3.941B |
0.00 |
| Legend Biotech (LEGN) |
United States |
$3.937B |
0.00 |
| Arena Pharmaceuticals (ARNA) |
United States |
$3.730B |
0.00 |
| SpringWorks Therapeutics (SWTX) |
United States |
$3.586B |
0.00 |
| Alkermes (ALKS) |
Ireland |
$3.572B |
0.00 |
| Apellis Pharmaceuticals (APLS) |
United States |
$3.563B |
0.00 |
| ACADIA Pharmaceuticals (ACAD) |
United States |
$3.487B |
0.00 |
| Emergent Biosolutions (EBS) |
United States |
$3.322B |
6.62 |
| Arvinas (ARVN) |
United States |
$3.278B |
0.00 |
| Intra-Cellular Therapies (ITCI) |
United States |
$3.053B |
0.00 |
| BAVARIAN NORDIC (BVNRY) |
Denmark |
$2.883B |
40.74 |
| Reata Pharmaceuticals (RETA) |
United States |
$2.842B |
0.00 |
| MorphoSys AG (MOR) |
Germany |
$2.751B |
0.00 |
| Insmed (INSM) |
United States |
$2.715B |
0.00 |
| Amicus Therapeutics (FOLD) |
United States |
$2.525B |
0.00 |
| Berkeley Lights (BLI) |
United States |
$2.477B |
0.00 |
| Vericel (VCEL) |
United States |
$2.353B |
634.63 |
| Instil Bio (TIL) |
United States |
$2.265B |
0.00 |
| Editas Medicine (EDIT) |
United States |
$2.253B |
0.00 |
| Global Blood Therapeutics (GBT) |
United States |
$2.253B |
0.00 |
| ALX Oncology Holdings (ALXO) |
United States |
$2.229B |
0.00 |
| NGM Biopharmaceuticals (NGM) |
United States |
$2.201B |
0.00 |
| Ligand Pharmaceuticals (LGND) |
United States |
$2.157B |
36.08 |
| Myriad Genetics (MYGN) |
United States |
$2.110B |
0.00 |
| Revance Therapeutics (RVNC) |
United States |
$2.079B |
0.00 |
| Seres Therapeutics (MCRB) |
United States |
$2.065B |
0.00 |
| Kymera Therapeutics (KYMR) |
United States |
$2.050B |
0.00 |
| Bluebird Bio (BLUE) |
United States |
$2.045B |
0.00 |
| Arcus Biosciences (RCUS) |
United States |
$2.025B |
0.00 |
| Dicerna Pharmaceuticals (DRNA) |
United States |
$2.016B |
0.00 |
| Heska (HSKA) |
United States |
$2.006B |
874.54 |
| Deciphera Pharmaceuticals (DCPH) |
United States |
$2.005B |
0.00 |
| Myovant Sciences (MYOV) |
United Kingdom |
$1.945B |
0.00 |
| Sorrento Therapeutics (SRNE) |
United States |
$1.898B |
0.00 |
| Atea Pharmaceuticals (AVIR) |
United States |
$1.896B |
0.00 |
| Cytokinetics (CYTK) |
United States |
$1.860B |
0.00 |
| PHARMA MAR SA (PHMMF) |
Spain |
$1.843B |
0.00 |
| Seer (SEER) |
|
$1.804B |
0.00 |
| Immunocore Holdings (IMCR) |
United Kingdom |
$1.738B |
0.00 |
| Ocugen (OCGN) |
United States |
$1.735B |
0.00 |
| Amarin (AMRN) |
Ireland |
$1.729B |
0.00 |
| Morphic Holding (MORF) |
United States |
$1.696B |
0.00 |
| Genetron Holdings (GTH) |
China |
$1.681B |
0.00 |
| Harmony Biosciences Holdings (HRMY) |
United States |
$1.586B |
0.00 |
| Sangamo Therapeutics (SGMO) |
United States |
$1.561B |
0.00 |
| REGENXBIO (RGNX) |
United States |
$1.536B |
0.00 |
| BioAtla (BCAB) |
United States |
$1.526B |
0.00 |
| Bionano Genomics (BNGO) |
United States |
$1.506B |
0.00 |
| C4 Therapeutics (CCCC) |
United States |
$1.505B |
0.00 |
| UniQure (QURE) |
Netherlands |
$1.493B |
0.00 |
| Y-mAbs Therapeutics (YMAB) |
United States |
$1.490B |
0.00 |
| PureTech Health (PRTC) |
United States |
$1.488B |
0.00 |
| ADC Therapeutics SA (ADCT) |
Switzerland |
$1.463B |
0.00 |
| Northwest Biotherapeutics (NWBO) |
United States |
$1.456B |
0.00 |
| Precigen (PGEN) |
United States |
$1.428B |
0.00 |
| Castle Biosciences (CSTL) |
United States |
$1.382B |
0.00 |
| Inovio Pharmaceuticals (INO) |
United States |
$1.372B |
0.00 |
| Alector (ALEC) |
United States |
$1.356B |
0.00 |
| Protagonist Therapeutics (PTGX) |
United States |
$1.339B |
0.00 |
| Zymeworks (ZYME) |
Canada |
$1.320B |
0.00 |
| Forma Therapeutics Holdings (FMTX) |
United States |
$1.267B |
0.00 |
| Zealand Pharma (ZEAL) |
Denmark |
$1.260B |
0.00 |
| Curis (CRIS) |
United States |
$1.242B |
0.00 |
| Avid Bioservices (CDMO) |
United States |
$1.222B |
0.00 |
| Repare Therapeutics (RPTX) |
Canada |
$1.198B |
0.00 |
| Codexis (CDXS) |
United States |
$1.180B |
0.00 |
| Zealand Pharma (ZLDPF) |
Denmark |
$1.167B |
0.00 |
| Nurix Therapeutics (NRIX) |
United States |
$1.151B |
0.00 |
| Coherus BioSciences (CHRS) |
United States |
$1.146B |
0.00 |
| Keros Therapeutics (KROS) |
United States |
$1.139B |
0.00 |
| Shattuck Labs (STTK) |
United States |
$1.123B |
0.00 |
| Travere Therapeutics (TVTX) |
United States |
$1.105B |
0.00 |
| OXFORD BIOMEDCL (OXBDF) |
United Kingdom |
$1.095B |
0.00 |
| MannKind (MNKD) |
United States |
$1.074B |
0.00 |
| Celldex Therapeutics (CLDX) |
United States |
$1.073B |
0.00 |
| MiMedx (MDXG) |
United States |
$1.058B |
0.00 |
| KaloBios Pharmaceuticals (HGEN) |
United States |
$1.041B |
0.00 |
| Vanda Pharmaceuticals (VNDA) |
United States |
$1.036B |
32.72 |
| Mersana Therapeutics (MRSN) |
United States |
$1.017B |
0.00 |
| Prothena (PRTA) |
Ireland |
$1.015B |
0.00 |
| Pliant Therapeutics (PLRX) |
United States |
$1.007B |
0.00 |
| Scholar Rock Holding (SRRK) |
United States |
$0.961B |
0.00 |
| Epizyme (EPZM) |
United States |
$0.931B |
0.00 |
| G1 THERAPEUTICS (GTHX) |
United States |
$0.922B |
0.00 |
| Nkarta (NKTX) |
United States |
$0.918B |
0.00 |
| Sutro Biopharma (STRO) |
United States |
$0.908B |
0.00 |
| Mesoblast (MESO) |
Australia |
$0.907B |
0.00 |
| Syndax Pharmaceuticals (SNDX) |
United States |
$0.894B |
0.00 |
| Dynavax Technologies (DVAX) |
United States |
$0.894B |
0.00 |
| Affimed (AFMD) |
Germany |
$0.865B |
0.00 |
| Merus (MRUS) |
Netherlands |
$0.849B |
0.00 |
| Pharming Group (PHAR) |
Netherlands |
$0.777B |
0.00 |
| Avidity Biosciences (RNA) |
United States |
$0.768B |
0.00 |
| Arcturus Therapeutics Holdings (ARCT) |
United States |
$0.760B |
0.00 |
| Pharming Group (PHGUF) |
Netherlands |
$0.754B |
20.08 |
| Adaptimmune Therapeutics (ADAP) |
United Kingdom |
$0.749B |
0.00 |
| Bicycle Therapeutics (BCYC) |
United Kingdom |
$0.749B |
0.00 |
| VBI Vaccines (VBIV) |
United States |
$0.742B |
0.00 |
| Agenus (AGEN) |
United States |
$0.718B |
0.00 |
| AnaptysBio (ANAB) |
United States |
$0.714B |
0.00 |
| Xenon Pharmaceuticals (XENE) |
Canada |
$0.710B |
0.00 |
| Cellectis S.A (CLLS) |
France |
$0.704B |
0.00 |
| DBV Technologies S.A (DBVT) |
France |
$0.691B |
0.00 |
| ZIOPHARM Oncology Inc (ZIOP) |
United States |
$0.683B |
0.00 |
| Bolt Biotherapeutics (BOLT) |
United States |
$0.683B |
0.00 |
| Cara Therapeutics (CARA) |
United States |
$0.661B |
57.39 |
| Orchard Therapeutics (ORTX) |
United Kingdom |
$0.657B |
0.00 |
| Sinovac Biotech (SVA) |
China |
$0.642B |
6.47 |
| IDEAYA Biosciences (IDYA) |
United States |
$0.642B |
0.00 |
| Kadmon Holdings (KDMN) |
United States |
$0.641B |
0.00 |
| Inhibrx (INBX) |
United States |
$0.632B |
0.00 |
| Anika Therapeutics (ANIK) |
United States |
$0.629B |
0.00 |
| Prometheus Biosciences (RXDX) |
United States |
$0.627B |
0.00 |
| Lexicon Pharmaceuticals (LXRX) |
United States |
$0.625B |
0.00 |
| Clovis Oncology (CLVS) |
United States |
$0.614B |
0.00 |
| Intercept Pharmaceuticals (ICPT) |
United States |
$0.602B |
0.00 |
| MeiraGTx Holdings (MGTX) |
United States |
$0.576B |
0.00 |
| ALBIREO PHARMA (ALBO) |
United States |
$0.574B |
0.00 |
| Adagene (ADAG) |
China |
$0.553B |
0.00 |
| Inventiva S.A (IVA) |
France |
$0.549B |
0.00 |
| Compugen (CGEN) |
Israel |
$0.547B |
0.00 |
| Precision BioSciences (DTIL) |
United States |
$0.546B |
0.00 |
| CytomX Therapeutics (CTMX) |
United States |
$0.530B |
0.00 |
| RAPT THERAPTICS (RAPT) |
United States |
$0.515B |
0.00 |
| XBiotech (XBIT) |
United States |
$0.513B |
0.00 |
| Nabriva Therapeutics AG (NBRV) |
Ireland |
$0.507B |
0.00 |
| Verastem (VSTM) |
United States |
$0.505B |
0.00 |
| Starpharma Holdings (SPHRY) |
Australia |
$0.503B |
0.00 |
| Basilea Pharmaceutica AG (BPMUF) |
Switzerland |
$0.494B |
0.00 |
| Athenex (ATNX) |
United States |
$0.475B |
0.00 |
| Neoleukin Therapeutics (NLTX) |
United States |
$0.475B |
0.00 |
| ChromaDex (CDXC) |
United States |
$0.469B |
0.00 |
| HOOKIPA Pharma (HOOK) |
United States |
$0.456B |
0.00 |
| Geron (GERN) |
United States |
$0.456B |
0.00 |
| AC Immune SA (ACIU) |
Switzerland |
$0.451B |
0.00 |
| Clene (CLNN) |
United States |
$0.435B |
0.00 |
| ANI Pharmaceuticals (ANIP) |
United States |
$0.434B |
11.97 |
| Cue Biopharma (CUE) |
United States |
$0.429B |
0.00 |
| Forte Biosciences (FBRX) |
United States |
$0.427B |
0.00 |
| Adicet Bio (ACET) |
United States |
$0.427B |
0.00 |
| Gritstone Bio (GRTS) |
United States |
$0.425B |
0.00 |
| Angion Biomedica (ANGN) |
United States |
$0.415B |
0.00 |
| Puma Biotechnology (PBYI) |
United States |
$0.414B |
0.00 |
| Spero Therapeutics (SPRO) |
United States |
$0.413B |
0.00 |
| Seelos Therapeutics (SEEL) |
United States |
$0.408B |
0.00 |
| SESEN BIO, INC (SESN) |
United States |
$0.405B |
0.00 |
| Codiak BioSciences (CDAK) |
United States |
$0.401B |
0.00 |
| Amryt Pharma (AMYT) |
United Kingdom |
$0.397B |
0.00 |
| BeyondSpring (BYSI) |
United States |
$0.382B |
0.00 |
| Athersys (ATHX) |
United States |
$0.375B |
0.00 |
| Aeglea BioTherapeutics (AGLE) |
United States |
$0.371B |
0.00 |
| Oncobiologics (OTLK) |
United States |
$0.363B |
0.00 |
| Fortress Biotech (FBIO) |
United States |
$0.358B |
0.00 |
| Paratek Pharmaceuticals (PRTK) |
United States |
$0.357B |
0.00 |
| Opthea (OPT) |
Australia |
$0.353B |
0.00 |
| Adverum Biotechnologies (ADVM) |
United States |
$0.353B |
0.00 |
| BioDelivery Sciences (BDSI) |
United States |
$0.351B |
14.24 |
| AquaBounty Technologies (AQB) |
United States |
$0.347B |
0.00 |
| Selecta Biosciences (SELB) |
United States |
$0.337B |
0.00 |
| XOMA (XOMA) |
United States |
$0.337B |
157.47 |
| SQZ Biotechnologies (SQZ) |
United States |
$0.331B |
0.00 |
| Theratechnologies (THTX) |
Canada |
$0.329B |
0.00 |
| Kala Pharmaceuticals (KALA) |
United States |
$0.327B |
0.00 |
| Autolus Therapeutics (AUTL) |
United Kingdom |
$0.323B |
0.00 |
| Syros Pharmaceuticals (SYRS) |
United States |
$0.323B |
0.00 |
| ProQR Therapeutics (PRQR) |
Netherlands |
$0.322B |
0.00 |
| Fulcrum Therapeutics (FULC) |
United States |
$0.322B |
0.00 |
| Cardiff Oncology (CRDF) |
United States |
$0.321B |
0.00 |
| UROGEN PHARMA (URGN) |
United States |
$0.318B |
0.00 |
| Innate Pharma S.A (IPHA) |
France |
$0.317B |
0.00 |
| WAVE Life Sciences (WVE) |
Singapore |
$0.310B |
0.00 |
| Cogent Biosciences (COGT) |
United States |
$0.308B |
0.00 |
| Frequency Therapeutics (FREQ) |
United States |
$0.296B |
0.00 |
| Bellus Health (BLU) |
Canada |
$0.285B |
0.00 |
| PDL BioPharma (PDLI) |
United States |
$0.283B |
0.00 |
| Kaleido Biosciences (KLDO) |
|
$0.269B |
0.00 |
| Talis Biomedical (TLIS) |
United States |
$0.258B |
0.00 |
| Kamada (KMDA) |
Israel |
$0.255B |
17.36 |
| EYEPOINT PHARMACEUTICALS, INC (EYPT) |
United States |
$0.255B |
0.00 |
| Arbutus Biopharma (ABUS) |
United States |
$0.253B |
0.00 |
| Trevena (TRVN) |
United States |
$0.249B |
0.00 |
| OVID THERAPEUTC (OVID) |
United States |
$0.243B |
2.39 |
| Chiasma (CHMA) |
United States |
$0.232B |
0.00 |
| AVEO Pharmaceuticals (AVEO) |
United States |
$0.232B |
0.00 |
| CorMedix Inc (CRMD) |
United States |
$0.230B |
0.00 |
| Prima BioMed (IMMP) |
Australia |
$0.230B |
0.00 |
| NextCure (NXTC) |
United States |
$0.225B |
0.00 |
| Cerecor (CERC) |
United States |
$0.210B |
0.00 |
| ADMA Biologics Inc (ADMA) |
United States |
$0.209B |
0.00 |
| Eton Pharmaceuticals (ETON) |
United States |
$0.202B |
0.00 |
| Kindred Biosciences (KIN) |
United States |
$0.197B |
0.00 |
| POXEL SA FRANCE (PXXLF) |
France |
$0.193B |
0.00 |
| OSMOTICA PHARM (OSMT) |
United States |
$0.192B |
0.00 |
| VTv Therapeutics (VTVT) |
United States |
$0.190B |
0.00 |
| Checkpoint Therapeutics (CKPT) |
United States |
$0.188B |
0.00 |
| GENFIT S.A (GNFT) |
France |
$0.187B |
0.00 |
| X4 Pharmaceuticals (XFOR) |
United States |
$0.180B |
0.00 |
| TELA Bio (TELA) |
United States |
$0.180B |
0.00 |
| Erytech Pharma SA (ERYP) |
France |
$0.177B |
0.00 |
| Aptinyx (APTX) |
United States |
$0.172B |
0.00 |
| Voyager Therapeutics (VYGR) |
United States |
$0.172B |
4.43 |
| Nicox SA (NICXF) |
France |
$0.170B |
0.00 |
| Applied Genetic Technologies (AGTC) |
United States |
$0.166B |
0.00 |
| Strongbridge Biopharma (SBBP) |
United States |
$0.159B |
0.00 |
| ObsEva SA (OBSV) |
Switzerland |
$0.157B |
0.00 |
| Antibe Therapeutics (ATBPF) |
Canada |
$0.154B |
0.00 |
| Biofrontera AG (BFRA) |
Germany |
$0.154B |
0.00 |
| LogicBio Therapeutics (LOGC) |
United States |
$0.152B |
0.00 |
| INmune Bio (INMB) |
United States |
$0.146B |
0.00 |
| Enzo Biochem (ENZ) |
United States |
$0.144B |
0.00 |
| Liquidia Technologies (LQDA) |
United States |
$0.141B |
0.00 |
| Synlogic (SYBX) |
United States |
$0.141B |
0.00 |
| Clearside Biomedical (CLSD) |
United States |
$0.137B |
0.00 |
| Abeona Therapeutics (ABEO) |
United States |
$0.137B |
0.00 |
| ABVC BioPharma (ABVC) |
United States |
$0.134B |
0.00 |
| Catalyst Biosciences (CBIO) |
United States |
$0.131B |
0.00 |
| PHASEBIO PHARMA (PHAS) |
United States |
$0.131B |
0.00 |
| Exicure (XCUR) |
United States |
$0.131B |
0.00 |
| Evofem Biosciences (EVFM) |
United States |
$0.129B |
0.00 |
| Liminal BioSciences (LMNL) |
Canada |
$0.128B |
0.00 |
| Novogen (KZIA) |
Australia |
$0.125B |
0.00 |
| Orgenesis (ORGS) |
United States |
$0.124B |
0.00 |
| Galena Biopharma (SLS) |
United States |
$0.123B |
0.00 |
| DiaMedica Therapeutics (DMAC) |
United States |
$0.122B |
0.00 |
| Pieris Pharmaceuticals (PIRS) |
United States |
$0.119B |
0.00 |
| Eyenovia (EYEN) |
United States |
$0.118B |
0.00 |
| ANIXA BIOSCIENCES INC (ANIX) |
United States |
$0.117B |
0.00 |
| Pluristem Therapeutics (PSTI) |
Israel |
$0.116B |
0.00 |
| Cocrystal Pharma (COCP) |
United States |
$0.110B |
0.00 |
| Beyond Air (XAIR) |
United States |
$0.103B |
0.00 |
| Dyadic (DYAI) |
United States |
$0.103B |
0.00 |
| Aptevo Therapeutics (APVO) |
United States |
$0.102B |
0.00 |
| Longeveron (LGVN) |
United States |
$0.100B |
0.00 |
| Cyclerion Therapeutics (CYCN) |
United States |
$0.100B |
0.00 |
| ARAVIVE, INC (ARAV) |
United States |
$0.098B |
0.00 |
| ASLAN Pharmaceuticals (ASLN) |
Singapore |
$0.098B |
0.00 |
| Cidara Therapeutics (CDTX) |
United States |
$0.097B |
0.00 |
| Aytu BioPharma (AYTU) |
United States |
$0.096B |
0.00 |
| TRACON Pharmaceuticals (TCON) |
United States |
$0.095B |
0.00 |
| Vascular Biogenics (VBLT) |
Israel |
$0.095B |
0.00 |
| Leap Therapeutics (LPTX) |
United States |
$0.094B |
0.00 |
| Celsion (CLSN) |
United States |
$0.090B |
0.00 |
| Evogene (EVGN) |
Israel |
$0.090B |
0.00 |
| Lumos Pharma (LUMO) |
United States |
$0.083B |
0.00 |
| AIkido Pharma (AIKI) |
United States |
$0.081B |
0.00 |
| Celyad SA (CYAD) |
Belgium |
$0.081B |
0.00 |
| CollPlant Biotechnologies (CLGN) |
Israel |
$0.079B |
0.00 |
| Edesa Biotech (EDSA) |
Canada |
$0.079B |
0.00 |
| Zosano Pharma (ZSAN) |
United States |
$0.079B |
0.00 |
| Adocia (ADOCY) |
France |
$0.077B |
0.00 |
| Cleveland BioLabs (CBLI) |
United States |
$0.072B |
0.00 |
| ARIDIS PHARMACT (ARDS) |
United States |
$0.072B |
0.00 |
| Purple Biotech (PPBT) |
Israel |
$0.070B |
0.00 |
| Entera Bio (ENTX) |
Israel |
$0.069B |
0.00 |
| Emmaus Life Sciences (EMMA) |
United States |
$0.066B |
0.00 |
| Stealth BioTherapeutics (MITO) |
Cayman Islands |
$0.066B |
0.00 |
| Cyclacel Pharmaceuticals (CYCC) |
United States |
$0.063B |
0.00 |
| Vaccinex (VCNX) |
United States |
$0.060B |
0.00 |
| F-star Therapeutics (FSTX) |
United Kingdom |
$0.060B |
0.00 |
| Alimera Sciences (ALIM) |
United States |
$0.059B |
0.00 |
| Appili Therapeutics (APLIF) |
Canada |
$0.059B |
0.00 |
| ATyr Pharma (LIFE) |
United States |
$0.059B |
0.00 |
| BioCardia (BCDA) |
United States |
$0.058B |
0.00 |
| ZIVO Bioscience (ZIVO) |
United States |
$0.057B |
0.00 |
| Advaxis (ADXS) |
United States |
$0.055B |
0.00 |
| Aerpio Pharmaceuticals (ARPO) |
United States |
$0.055B |
0.00 |
| AEterna Zentaris (AEZS) |
United States |
$0.055B |
0.00 |
| Genetic Technologies (GENE) |
Australia |
$0.054B |
0.00 |
| Idera Pharmaceuticals (IDRA) |
United States |
$0.051B |
0.00 |
| AnPac Bio-Medical Science (ANPC) |
China |
$0.050B |
0.00 |
| Pulmatrix (PULM) |
United States |
$0.049B |
0.00 |
| Organovo Holdings (ONVO) |
United States |
$0.049B |
0.00 |
| Windtree Therapeutics (WINT) |
United States |
$0.046B |
0.00 |
| Cyclo Therapeutics (CYTH) |
United States |
$0.045B |
0.00 |
| Happiness Biotech Group (HAPP) |
China |
$0.043B |
0.00 |
| Acorda Therapeutics (ACOR) |
United States |
$0.043B |
1.03 |
| Enveric Biosciences (ENVB) |
United States |
$0.042B |
0.00 |
| Invo BioScience (INVO) |
United States |
$0.041B |
0.00 |
| Yumanity Therapeutics (YMTX) |
United States |
$0.037B |
0.00 |
| Vyant Bio (VYNT) |
United States |
$0.037B |
0.00 |
| Soligenix (SNGX) |
United States |
$0.036B |
0.00 |
| GeoVax Labs (GOVX) |
United States |
$0.033B |
0.00 |
| Lexaria Bioscience (LEXX) |
Canada |
$0.032B |
0.00 |
| Prana Biotechnology (ATHE) |
Australia |
$0.028B |
0.00 |
| IMMURON (IMRN) |
Australia |
$0.028B |
0.00 |
| Sonnet BioTherapeutics Holdings (SONN) |
United States |
$0.028B |
0.00 |
| ThermoGenesis Holdings (THMO) |
United States |
$0.026B |
0.00 |
| Vallon Pharmaceuticals (VLON) |
United States |
$0.025B |
0.00 |
| Titan Pharmaceuticals (TTNP) |
United States |
$0.023B |
0.00 |
| Benitec Biopharma (BNTC) |
United States |
$0.022B |
0.00 |
| Palisade Bio (PALI) |
United States |
$0.011B |
0.00 |
| ImmunityBio (IBRX) |
United States |
$0.000B |
0.00 |
| Immatics (IMTX) |
United States |
$0.000B |
0.00 |
| Viridian Therapeutics (VRDN) |
United States |
$0.000B |
0.00 |
